Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 2/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | CASP7 | P55210 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25790838 | 0.81 | POLB (0.38) | GPR3BACE1BCHEACHEATM | |
| SCHEMBL15615581 | 0.80 | GPR3 (0.46) | GPR3BACE1BCHEACHEATM | |
| SCHEMBL150044 | 0.80 | BCHE (0.59) | GPR3BACE1BCHEACHEATM | |
| SCHEMBL29780042 | 0.80 | BCHE (0.59) | GPR3BACE1BCHEACHEATM | |
| SCHEMBL26446062 | 0.80 | GPR3 (0.52) | GPR3BACE1BCHEACHEATM | |
| SCHEMBL23052870 | 0.80 | KDM4E (0.55) | BCHEACHEATMMAPTKMT2A | |
| SCHEMBL4615211 | 0.76 | BACE1 (0.48) | GPR3BACE1BCHEACHEATM | |
| SCHEMBL19055784 | 0.76 | GPR3 (0.48) | GPR3BACE1BCHEACHEATM | |
| SCHEMBL22325589 | 0.76 | GPR3 (0.48) | GPR3BACE1BCHEACHEATM | |
| SCHEMBL27707046 | 0.76 | GPR3 (0.48) | GPR3BACE1BCHEACHEATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10700288-B2 | Light-emitting element, light-emitting device, electronic device, lighting device, and lighting system | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2020-06-30 | — | — | US | disclosed |
| EP-3375868-A1 | STIMULATION OF ANTI-TUMOR IMMUNITY USING DENDRITIC CELL/TUMOR CELL FUSIONS AND ANTI-CD3/CD28 | Dana Farber Cancer Institute, Inc. (US) | 2018-09-19 | — | — | EP | disclosed |
| EP-2215220-B1 | STIMULATION OF ANTI-TUMOR IMMUNITY USING DENDRITIC CELL/TUMOR CELL FUSIONS AND ANTI-CD3/CD28 | DANA FARBER CANCER INST INC (US) | 2018-01-10 | — | — | EP | disclosed |
| CN-104031400-B | A kind of preparation method of permanent violet pigment | NANTONG HAIDI CHEMICALS CO., LTD. (CN) | 2016-04-27 | — | — | CN | disclosed |
| CN-1311820-B | BASB027 protein and BASB027 gene from Moraxella catarrhalis, antigens, antibodies and uses | SMITHKLINE BEECHAM BIOLOG | 2011-11-16 | — | — | CN | disclosed |
| US-20100278873-A1 | STIMULATION OF ANTI-TUMOR IMMUNITY USING DENDRITIC CELL/TUMOR CELL FUSIONS AND ANTI-CD3/CD28 | NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR | 2010-11-04 | — | — | US | disclosed |
| EP-2215220-A1 | STIMULATION OF ANTI-TUMOR IMMUNITY USING DENDRITIC CELL/TUMOR CELL FUSIONS AND ANTI-CD3/CD28 | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2010-08-11 | — | — | EP | disclosed |
| CN-101544594-A | Method for preparing 3-amino-9-ethyl carbazole by green catalysis method | NANTONG HAIDI CHEMICALS CO LTD | 2009-09-30 | — | — | CN | disclosed |
| CN-101481409-A | BASB027 proteins and genes from Moraxella catarrhalis, antigens, antibodies, and uses | GLAXOSMITHKLINE BIOLOG SA (BE) | 2009-07-15 | — | — | CN | disclosed |
| WO-2009062001-A1 | STIMULATION OF ANTI-TUMOR IMMUNITY USING DENDRITIC CELL/TUMOR CELL FUSIONS AND ANTI-CD3/CD28 | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2009-05-14 | — | — | WO | disclosed |
| EP-0906571-A1 | LABELLING AND SELECTION OF MOLECULES | Cambridge Antibody Technology Limited (GB) | 1999-04-07 | — | — | EP | disclosed |
| WO-1998001757-A1 | LABELLING AND SELECTION OF MOLECULES | CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED (GB) | 1998-01-15 | — | — | WO | disclosed |
| CN-1154705-A | Organic compound | SANDOZ LTD (CH) | 1997-07-16 | — | — | CN | disclosed |
| EP-0648226-A1 | NATURAL HUMAN IgM ANTIBODIES | INSTITUTE FOR HUMAN GENETICS AND BIOCHEMISTRY (CH) | 1995-04-19 | — | — | EP | disclosed |
| US-5378604-A | Diagnostic kits for gingivitis and periodontitis | MICROPROBE CORPORATION (US) | 1995-01-03 | — | — | US | disclosed |
| EP-0395731-A4 | OLIGONUCLEOTIDE PROBES FOR DETECTION OF PERIODONTAL PATHOGENS | — | 1993-12-01 | — | — | EP | disclosed |
| WO-1993022349-A1 | NATURAL HUMAN IgM ANTIBODIES | THE INSTITUTE FOR HUMAN GENETICS AND BIOCHEMISTRY (CH) | 1993-11-11 | — | — | WO | disclosed |
| US-5212059-A | Oral pathogens | MICROPROBE CORPORATION (US) | 1993-05-18 | — | — | US | disclosed |
| EP-0395731-A1 | OLIGONUCLEOTIDE PROBES FOR DETECTION OF PERIODONTAL PATHOGENS | MICROPROBE CORPORATION (US) | 1990-11-07 | — | — | EP | disclosed |
| WO-1989006704-A1 | OLIGONUCLEOTIDE PROBES FOR DETECTION OF PERIODONTAL PATHOGENS | MICROPROBE CORPORATION (US) | 1989-07-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10700288-B2 | Light-emitting element, light-emitting device, electronic device, lighting device, and lighting system | LAGE3, TEAD1, TEAD4 | GPR3 3271/4885BACE1 2763/4885BCHE 2403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.